Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05964088 · ClinicalTrials.gov registry record
Mortality and Morbidity Associated With New Onset Acute Kidney Injury in Critically Ill COVID-19 Infection Patients
A clinical trial, sponsored by Arrowhead Regional Medical Center.
- Completed
- Registry status
- 267
- Enrollment target
NCT05964088: Completed study, sponsored by Arrowhead Regional Medical Center.
NCT05964088 is a clinical trial that has completed, run by Arrowhead Regional Medical Center. The registered enrollment target is 267 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05964088 has completed, sponsored by Arrowhead Regional Medical Center.
- COMPLETED
- Registry status
- 267 participants
- Enrollment target
Study Summary
This study explored the incidence of morbidity and mortality associated with AKI in critically ill adult patients infected with COVID-19. There are two groups for comparison. Group1. patients were directly admitted to the intensive care unit (ICU) from the emergency department (ED) Group 2. patients were initially managed on the medical floor and later transferred to the ICU for worsening respiratory status. The investigating team evaluated the correlation of inflammatory markers and common risk factors such as obesity, diabetes, hypertension and ethnicity to the development of AKI in the target population. The primary outcome is mortality participants will received their regular healthcare in a medical setting
Primary Outcome
mortality at hospital discharge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 267 participants |
| Start Date | 2020-03-01 |
| Est. Completion | 2022-02-12 |
What the finished NCT05964088 record still lists
NCT05964088 is an observational study that tracks outcomes without assigning an intervention. The registered 267 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT05964088 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05964088 about?
NCT05964088 is a clinical study titled "Mortality and Morbidity Associated With New Onset Acute Kidney Injury in Critically Ill COVID-19 Infection Patients". This study explored the incidence of morbidity and mortality associated with AKI in critically ill adult patients infected with COVID-19. There are two groups for comparison. Group1. patients were directly admitted to the intensive care unit (ICU) from the emergency department (ED) Group 2. patients...
What is the current status of trial NCT05964088?
This trial is currently completed. The enrollment target is 267 participants. The study started on 2020-03-01. Estimated completion is 2022-02-12.
Who is sponsoring clinical trial NCT05964088?
This trial is sponsored by Arrowhead Regional Medical Center, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04997109 · 267 participants · NA
Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy
- NCT05355701 · 267 participants · Phase 1
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
- NCT06203509 · 267 participants · NA
Improving Care Transitions for Medicaid Insured Individuals With Co-occurring Serious Mental Illness
- NCT05000632 · 268 participants · NA
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI